Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

Particle Therapeutics is a drug delivery company developing innovative particle formulation and drug delivery technologies to improve the efficacy and administration of a range of pharmaceuticals.

Incorporated in June 2006

Origin: Oxford University, Department of Engineering Science

Provides advanced insights on global information operations, data flows, and public understanding of critical issues.

Incorporated in December 2022

Origin: Oxford University, Oxford Internet Institute

Therapeutics biotech company developing proprietary drug delivery platform technology.

Incorporated in March 2018

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.

Incorporated in April 2013

Origin: Oxford University, Radcliffe Department of Medicine

Drug Design.

Incorporated in December 2000

Origin: Oxford University, Department of Computer Science

Anti-cancer drugs.

Incorporated in January 2002

Origin: Oxford University, Department of Chemistry

Drug/Vaccine Delivery.

Incorporated in October 1994

Origin: Oxford University

Software enabled system for orthopaedic care pathway management, implant safety monitoring and patient reported outcome delivery.

Incorporated in March 2017

Origin: Oxford University, NDORMS & NDPH

Antibiotics.

Incorporated in June 1998

Origin: Oxford University, Department of Pathology

Proxisense specialise in advanced sensors, diagnostics and optimisation systems to prevent downtime & equipment failure. They improve performance & efficiency of complex rotating equipment.

Incorporated in October 2016

Origin: Oxford University, Department of Engineering Science

High heat flux technology. The company will provide advanced engineering solutions to challenging thermal problems such as those that occur in fusion reactors, or high power density electronic systems.

Incorporated in April 2020

Origin: Oxford University, Thermofluids Institute

Contact: Adrian Coles

Machine learning algorithm and codes for quantum computers.

Incorporated in October 2021

Origin: Oxford University, Department of Materials

Developing mass photometry - a revolutionary new way to analyse molecules. It enables the accurate mass measurement of single molecules in solution, in their native state and without the need for labels.

Incorporated in June 2018

Origin: Oxford University, Department of Chemistry

Contact: Adam Workman

Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation